Volume 26, Number 6—June 2020
Research
Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department
Matias Chiarastelli Salomão
, Maristela Pinheiro Freire, Icaro Boszczowski, Sueli F. Raymundo, Ana Rubia Guedes, and Anna S. Levin
, Maristela Pinheiro Freire, Icaro Boszczowski, Sueli F. Raymundo, Ana Rubia Guedes, and Anna S. Levin
Table 2
Multivariate analysis for potential factors associated with colonization by carbapenem-resistant Enterobacteriaceae at ICU admission, Hospital das Clínicas, São Paulo, Brazil, September 2015–July 2017*
| Covariate | OR (95% CI) | p value |
|---|---|---|
| ED stay >2 d | 5.85 (1.94–17.65) | 0.002 |
| Transfer from another hospital | 2.10 (0.95–4.78) | 0.076 |
| SAPS 3 score | 1.02 (1.003–1.03) | 0.02 |
| Carbapenem use on ICU admission, initiated >48 h before ICU admission | 4.78 (1.31–17.47) | 0.02 |
| Infection at ICU admission | 2.86 (1.08–7.55) | 0.03 |
| Upper digestive endoscopy | 16.40 (2.16–124.50) | 0.01 |
*Model using length of ED stay as dichotomous variable. OR, odds ratio; ED, emergency department; ICU, intensive care unit; SAPS 3, Simplified Acute Physiology Score III.
Page created: May 18, 2020
Page updated: May 18, 2020
Page reviewed: May 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.